Approximately 80% of GIST have activating mutations in the KIT receptor tyrosine kinase gene and approximately 5–10% have activating mutations in the platelet-derived growth factor receptor alpha (PDGFRA) tyrosine kinase gene [2–4]. This evidence concerns the gene NTRK1 and gastrointestinal stromal tumor.